Fuzhou
China
Fujian Medical University - Fujian Provincial Hospital
EGFR-mutant, early-stage NSCLC, (neo)adjuvant targeted therapy, Neoadjuvant immunotherapy, ctDNA
single-cell RNA sequencing, post-COVID-19 pulmonary fibrosis, B cell dysregulation, immune biomarker
Community-acquired pneumonia, Precision antimicrobial therapy, Molecular diagnostics, Metagenomic next-generation sequencing, Respiratory failure, In-hospital mortality, Retrospective cohort study